Parameswaran Nair

University of British Columbia — Canada

Medicine · Health Sciences

62h-index18.2kcitations413works7.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(290), Respiratory and Cough-Related Research(112), Eosinophilic Esophagitis(75), Chronic Obstructive Pulmonary Disease (COPD) Research(69), IL-33, ST2, and ILC Pathways(63)

Publications410 total

Future of Cardiology Training And Practice Data Survey
Canadian Journal of Cardiology·2026Open Access
Perfusable 3D models of ureteric bud and collecting duct tubules
Cell Biomaterials·2025
Targeted Treatment in Asthma—Opportunities and Challenges
The Journal of Allergy and Clinical Immunology In Practice·2025· 1 citedOpen Access
Efficacité des thérapies anti-IL-5/IL-5 récepteur sur les manifestations spécifiques de la granulomatose éosinophilique avec polyangéite
La Revue de Médecine Interne·2025
S1 Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO
2025· 1 cited
Benralizumab reduces sputum ANCA in Patients with Eosinophilic Granulomatosis with Polyangiitis
ERJ Open Research·2025Open Access
Effects of benralizumab on serum biomarkers and biomarker response after shifting from mepolizumab to benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA)
2025
Late Breaking Abstract - Cytokine micro-environment in moderate-to-severe asthma with airway autoantibodies
2025
Late Breaking Abstract - Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO
2025
Neutrophilic asthma may not be a distinct endotype
ERJ Open Research·2025Open Access
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Annals of the Rheumatic Diseases·2025· 6 citedOpen Access
A novel method to assess airway eosinophilia using sputum plugs
ERJ Open Research·2025· 1 citedOpen Access
Eosinophils in asthma phenotypes: perpetrators or guilty by association?
The Lancet Respiratory Medicine·2025· 8 citedOpen Access
Perfusable 3D models of ureteric bud and collecting duct tubules
2025Open Access
Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging
American Journal of Respiratory and Critical Care Medicine·2025· 5 cited
For which food allergens does omalizumab raise the allergic reaction threshold?
Evidence-Based Practice·2025
OP0166 EFFICACY AND SAFETY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Annals of the Rheumatic Diseases·2025Open Access
Achieving remission in severe asthma
Chinese Medical Journal - Pulmonary and Critical Care Medicine·2025· 6 citedOpen Access
POS0327 EFFICACY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES ACCORDING TO HISTORIC DISEASE SEVERITY IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Annals of the Rheumatic Diseases·2025Open Access
Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease
Respirology·2025· 9 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Manali Mukherjee(10), Katherine Radford(8), Melanie Kjarsgaard(7), Paul M. O’Byrne(7), James G. Martin(7), Louis‐Philippe Boulet(6), Giorgio Walter Canonica(6), Nicola A. Hanania(6), Sarah Svenningsen(6), Chynna Huang(5), Catherine Lemière(5), Roma Sehmi(5), Nikolaos G. Papadopoulos(5), Luis Pérez de Llano(5), Arnaud Bourdin(4), Ioana Agache(4), Cezmi A. Akdiş(4), Mübeccel Akdiş(4), Thomas B. Casale(4), Jonathan Corren(4)